High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy
Jan Spanholtz(AIMM Therapeutics (Netherlands)), Harry Dolstra(Radboud University Nijmegen), Theo M. de Witte(Radboud University Nijmegen), Irma Joosten(Radboud University Nijmegen), Marleen Tordoir(Radboud University Nijmegen), Frank Preijers, Nicolaas Schaap(Radboud University Nijmegen), Arnold van der Meer(Radboud University Nijmegen), Diana Eissens(Radboud University Nijmegen)
Cited by 183
Related Papers
Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis
|Nature Genetics|2009|538
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022
|Bone Marrow Transplantation|2022|378
Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
|PLoS ONE|2011|239
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients
|Clinical Cancer Research|2017|211
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
|Frontiers in Immunology|2017|197